ALCON FDA Approval ANDA 083342

ANDA 083342

ALCON

FDA Drug Application

Application #083342

Application Sponsors

ANDA 083342ALCON

Marketing Status

Discontinued001

Application Products

001OINTMENT;OPHTHALMICEQ 0.05% PHOSPHATE0MAXIDEXDEXAMETHASONE SODIUM PHOSPHATE

FDA Submissions

ORIG1AP1973-10-23
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1984-06-19
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1984-04-12
LABELING; LabelingSUPPL8AP1989-09-21
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1990-02-23
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1991-09-25
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1993-02-03
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1992-06-05
LABELING; LabelingSUPPL13AP1993-09-27
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1999-03-23

Submissions Property Types

SUPPL5Null0
SUPPL6Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL14Null0

CDER Filings

ALCON
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 83342
            [companyName] => ALCON
            [docInserts] => ["",""]
            [products] => [{"drugName":"MAXIDEX","activeIngredients":"DEXAMETHASONE SODIUM PHOSPHATE","strength":"EQ 0.05% PHOSPHATE","dosageForm":"OINTMENT;OPHTHALMIC","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"MAXIDEX","submission":"DEXAMETHASONE SODIUM PHOSPHATE","actionType":"EQ 0.05% PHOSPHATE","submissionClassification":"OINTMENT;OPHTHALMIC","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.